Siemens Healthineers AG (LON:0PMJ)
London
· Delayed Price · Currency is GBP · Price in EUR | Market Cap | 41.28B |
| Revenue (ttm) | 20.32B |
| Net Income (ttm) | 1.85B |
| Shares Out | n/a |
| EPS (ttm) | 1.65 |
| PE Ratio | 22.33 |
| Forward PE | 17.51 |
| Dividend | 0.87 (2.05%) |
| Ex-Dividend Date | Feb 6, 2026 |
| Volume | 46,091 |
| Average Volume | 1,158,991 |
| Open | 42.43 |
| Previous Close | 42.35 |
| Day's Range | 42.02 - 42.43 |
| 52-Week Range | 39.93 - 54.46 |
| Beta | 0.84 |
| RSI | 50.36 |
| Earnings Date | Feb 5, 2026 |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the readin... [Read more]
Financial Performance
In fiscal year 2025, Siemens Healthineers AG's revenue was 23.38 billion, an increase of 4.53% compared to the previous year's 22.36 billion. Earnings were 2.14 billion, an increase of 10.40%.
Financial numbers in EUR Financial StatementsNews
EQS-DD: Siemens Healthineers AG: Dorothea Simon, Purchase of Siemens Healthineers Shares in connection with Siemens Healthineers Share Programs: 1) Purchase in the amount of 200.00 EUR per month ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 17.02.2026 / 16:49 CET/CEST The issuer is solely responsi...
EQS-DD: Siemens Healthineers AG: Dorothea Simon, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 13.02.2026 / 14:59 CET/CEST The issuer is solely responsi...
Siemens Healthineers AG (SMMNY) Q1 2026 Earnings Call Highlights: Strong Imaging and Precision ...
Siemens Healthineers AG (SMMNY) Q1 2026 Earnings Call Highlights: Strong Imaging and Precision Therapy Growth Amidst Diagnostics Challenges
Q1 2026 Siemens Healthineers AG Earnings Call Transcript
Q1 2026 Siemens Healthineers AG Earnings Call Transcript
Siemens Healthineers AG (SMMNY) Q1 2026 Earnings Call Transcript
Siemens Healthineers AG (SMMNY) Q1 2026 Earnings Call Transcript
Siemens Healthineers AG 2026 Q1 - Results - Earnings Call Presentation
Siemens Healthineers Core Businesses Offset Currency, Tariff Challenges
Revenue grew on a comparable basis as results in its imaging and precision therapy business units offset currency and tariff headwinds.
Siemens Healthineers (SEMHF) Reports Q1 Results with Revenue of â¬5.4B
Siemens Healthineers (SEMHF) Reports Q1 Results with Revenue of â¬5.4B
Siemens Healthineers AG Q1 Income Falls
BRUSSELS (dpa-AFX) - Siemens Healthineers AG (SMMNY.PK) released a profit for first quarter that Drops, from last yearThe company's bottom line came in at EUR449 million, or EUR0.40 per share. Thi...
Siemens Healthineers reports Q1 results
Siemens Healthineers beats Q1 profit estimates on strong imaging unit margins
Siemens Healthineers reported first-quarter operating profit above market expectations on Thursday, as strong margin performance in its core imaging and cancer-care units helped cushion a slump in its...
Polen International Growth adds Nintendo, exits Teleperformance and Siemens Healthineers in Q4
Siemens Healthineers: Potentially Much Stronger Than Siemens In 2026E
Siemens Healthineers (SEMHF) is undervalued, offering strong safety and upside, and remains a top 'BUY' pick for 2026. Key risks center on muted China growth, but ex-China performance is robust, with ...
5 European AI Stocks to Track in Q1 2026
While the artificial intelligence boom has continued to gather momentum in the United States and China, Europe's strengthening role in AI markets may be undervalued by investors, opening the door to f...
Siemens Healthineers AG (SMMNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Siemens Healthineers AG (SMMNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Siemens Healthineers AG (SMMNY) Analyst/Investor Day Transcript
Siemens Healthineers AG (OTCPK:SMMNY) Analyst/Investor Day November 17, 2025 8:00 AM EST Company Participants Bernhard Montag - President, CEO & Chairman of Management Board Jochen Schmitz - CFO & Mem...
Siemens Healthineers: Healthcare Remains Attractive After 2025
Siemens Healthineers remains a Buy, offering 15% annualized upside. Strong 2025 results, margin expansion, and resilient growth in Imaging and Varian segments support the investment case, despite Chin...
Siemens Healthineers preparing for potential Siemens's share sale -CFO
Siemens Healthineers is preparing for the possibility that its biggest shareholder Siemens AG may reduce its stake in the medical technology company to less than 50%, its CFO said on Wednesday.
Siemens Healthineers AG (SMMNY) Q4 2025 Press Conference Call Transcript
Siemens Healthineers AG (OTCPK:SMMNY) Q4 2025 Press Conference Call November 5, 2025 4:00 AM EST Company Participants Matthias Kraemer Bernhard Montag - President, CEO & Chairman of Management Board J...
Siemens Healthineers AG (SMMNY) Q4 2025 Earnings Call Transcript
Siemens Healthineers AG (OTCPK:SMMNY) Q4 2025 Earnings Call November 5, 2025 2:00 AM EST Company Participants Marc Koebernick - Head of Investor Relations Bernhard Montag - President, CEO & Chairman o...
Siemens Healthineers Reports Fall in Profits, Citing Tariffs
Higher comparable revenue stemming from the transformation program of its diagnostics business was offset by a hit from U.S. tariffs.
Siemens Healthineers slightly misses sales expectations in fourth quarter
Siemens Healthineers on Wednesday reported fourth-quarter revenue slightly below analysts' consensus as higher U.S. import tariffs weigh.
New Drug Testing Analyzer from Siemens Healthineers Raises the Bar for Court, Military, and Forensics Testing, Offering Clinical-Quality Results
TARRYTOWN, N.Y.--(BUSINESS WIRE)-- #drugtesting--New drug testing analyzer helps identify substance use, monitor therapeutic and immunosuppressant drugs, and perform serum toxicology testing.
Siemens Healthineers AG - Special Call
Siemens Healthineers AG - Special Call Company Participants Presentation Unknown Executive Welcome to our pre-close catch-up for Q4 fiscal year 2025, which was recorded on September 25, 2025. In this ...
VedaBio Announces Strategic Agreement with Siemens Healthineers and Series A Extension, Totaling Up to $25 Million
SAN DIEGO--(BUSINESS WIRE)--VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a Series A extension alongside a strategic agreement with Siemens Healthineers...